Vai al contenuto principale
xMedica

NCT06942949ClinicalTrials.gov

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

In reclutamentoAccetta partecipanti ora, secondo la scheda del registro.
Contatta questo studio

In breve

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less…

Interventistico101 partecipanti ricercati20 centri1 paese

Categorie

Registrato in 1 registro

Uno studio può essere registrato in più registri. Lo mostriamo una volta sola e colleghiamo ogni scheda in nostro possesso.

Le informazioni sulla sperimentazione sono mostrate così come pubblicate dal registro, nella lingua originale.

Ti interessa questo studio?

Accedi oppure crea un account per registrare il tuo interesse e seguire questo studio.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2025-04-24; recorded start 2025-05-01
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Not stated: Participants are not randomly assignedAllocation is recorded as non-randomised
  • Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
  • Not stated: Open label (no blinding)Masking is recorded as none (open label)
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Not stated: No other studies from this sponsor are in this databaseCounted from the lead sponsor named in the record (Avvio Medical)
  • Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourEXPLORATORY

An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation0/20

    Allocation not stated in the record

  • Blinding0/20

    Open-label

  • Control arm0/15

    No comparator arm stated in the record

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre8/8

    Multi-centre: 20 sites

  • Data monitoring committee0/7

    No data monitoring committee stated

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleSMALL

A small study: 101 participants (target), run at 20 sites.

How this score is built
  • Enrolment18/40

    101 participants (target)

  • Site count15/25

    20 sites

  • Country count0/15

    Single country

  • Planned duration6/10

    Planned over about 16 months

  • Sponsor scale0/10

    Avvio Medical has led 1 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

Sintesi

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be evaluated 30 days later for the presence or absence of urinary stone fragments on a CT scan. Subjects who still have stone present at Day 30 will be evaluated again at Day 60. Other outcome measures will be changes in pain, quality of life, and return to normal daily activities/work.

Patologie

  • Kidney Calculi; Ureteral Calculi

Idoneità

Idoneità
SessoTutti
Età21 YearsNessun massimo
Volontari saniNo

Idoneità come riportata nel registro

Inclusion Criteria: * Male or Female aged \>=21 Years * Provides written informed consent * One urinary stone within the ureter, size \>=5 mm and \<=10 mm present on CT * Stone is indicated for Shock Wavve Lithotrips Per AUA 2026 guidelines * Stone to be treated has a maximum density of \<= 1200 HU Exclusion Criteria: * Anatomic presentations that would preclude obtaining an acoustic window for the ultrasound treatment * Non-calcium based stones (e.g., uric acid stones) * Untreated UTI * Presence of abnormal skin conditions in the area to be treated * Coagulation abnormality * Inability to lay still for 30 minutes * Pregnant * Abnormal Kidney Function * Any genitourinary history or procedure that has altered anatomy (e.g. urinary tract reconstruction)

Idoneità in frasi semplici

I criteri di questa scheda non sono ancora stati suddivisi in affermazioni distinte. Il testo del registro qui sopra è completo ed è la versione autorevole.

Disegno dello studio

Disegno dello studio
Tipo di studioInterventistico
FaseNon applicabile
AssegnazioneNon applicabile
Modello di interventoSINGLE_GROUP
Finalità principaleTREATMENT
MascheramentoNONE (0)
Arruolamento101 partecipanti ricercati

Sponsor e collaboratori

  • Avvio Medical Sponsor

Bracci e interventi

  • The ELS Trial is a prospective, multi-center, single arm study.EXPERIMENTAL

    All Subjects who qualify to participate in the ELS Trial will receive the experimental ELS procedure.

Interventi

  • Dispositivo ELS (Enhanced Lithotripsy System)

    ELS (Enhanced Lithotripsy System) utilizes low pressure ultrasound to actuate proprietary microbubbles administered into the urine to pit and fragment urinary stones.

Esiti misurati

  1. Esito primario

    Primary Outcome Measure

    CT assessment of the target stone demonstrating either (i) stone free status (zero fragments) or (ii) the presence of only stone fragments small enough to pass spontaneously (\<=4 mm) at 30 Days post procedure.

    Orizzonte temporale From ELS treatment to 30 Days afterward.

Date

Date
Data di inizio1 maggio 2025 (effettiva)
Conclusione primaria1 agosto 2026 (stimata)
Conclusione1 settembre 2026 (stimata)
Prima pubblicazione24 aprile 2025 (effettiva)
Ultimo aggiornamento16 giugno 2026
Risultati pubblicatiNon indicato nella scheda del registro
Stato verificato l'ultima voltaluglio 2025

«Effettiva» significa che l'evento è avvenuto. «Stimata» significa che lo sponsor lo prevede. Le due cose non sono equivalenti.

Centri

12 centri stanno reclutando

United States

United States
StrutturaCittàStato o regioneStato
Michael G. Oefelein Clinical TrialsBakersfieldCaliforniaAttivo, non in reclutamento
University of VirginiaCharlottesvilleVirginiaRitirato
University of Virginia Community HealthCulpeperVirginiaAttivo, non in reclutamento
DukeDurhamNorth CarolinaAttivo, non in reclutamento
San Diego Clinical TrialsLa MesaCaliforniaIn reclutamento
Comprehensive Urologic CareLake BarringtonIllinoisIn reclutamento
Nebraska UrologyLincolnNebraskaNon indicato
Arkansas Urology Research CenterLittle RockArkansasNon indicato
University of Miami HospitalMiamiFloridaIn reclutamento
Arizona State Urological Research InstitutePhoenixArizonaIn reclutamento
Urology NevadaRenoNevadaNon indicato
University of Rochester Medical CenterRochesterNew YorkIn reclutamento
Georgia UrologyRoswellGeorgiaIn reclutamento
Golden State UrologySacramentoCaliforniaIn reclutamento
Urology San AntonioSan AntonioTexasIn reclutamento
Urology Specialists ClinicSioux CitySouth DakotaNon indicato
SUNY - Upstate Medical UniversitySyracuseNew YorkIn reclutamento
Urology of VirginiaVirginia BeachVirginiaIn reclutamento
Wichita Urology GroupWichitaKansasIn reclutamento
Minnesota UrologyWoodburyMinnesotaIn reclutamento

Documenti dello studio

In questa scheda del registro non sono collegati documenti.

Modifiche nel tempo

Non è stata registrata alcuna modifica da quando abbiamo acquisito questa scheda.

Viene registrata una modifica ogni volta che lo sponsor aggiorna la scheda del registro. Stato, date, arruolamento e centri compaiono qui man mano che cambiano.